-
Mashup Score: 6Why A Biopharma Executive Founded A Game-Changing Conference - 23 hour(s) ago
Amir Kalali, M.D., former global head of Quintiles (now IQVIA) neuroscience center of excellence, provides insight on why he decided to found an educational conference, The CNS Summit, while still working as a biopharmaceutical industry executive.
Source: www.lifescienceleader.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1More Competition in Oncology, State Regs May Impact Biopharma - 1 month(s) ago
An analysis of 3 trends that are shaping the biopharma market.
Source: www2.deloitte.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0Here are the best biopharma CEOs of 2023 - 3 month(s) ago
It’s that time of the year: @adamfeuerstein selects the best biopharma CEOs of 2023.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Three Factors May Be Shaping Priorities At Biopharma Companies - 3 month(s) ago
Three factors that appear to be shaping, and may continue to influence, the biopharmaceutical sector.
Source: www2.deloitte.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3Roivant's CEO is a star, but even a blockbuster deal can't escape biotech's black hole - 5 month(s) ago
Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2EMA Predicts Biopharma Industry to Increase Its Use of AI - 7 month(s) ago
AI/ML can be used to individualize treatment in relation to factors such as disease characteristics, patient genotype, wide-band biomarker panels, and clinical parameters.
Source: www.genengnews.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1EMA Predicts Biopharma Industry to Increase Its Use of AI - 8 month(s) ago
AI/ML can be used to individualize treatment in relation to factors such as disease characteristics, patient genotype, wide-band biomarker panels, and clinical parameters.
Source: www.genengnews.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Biopharma’s IRA Readiness: From What? To Now what? - 8 month(s) ago
The IRA may be a catalyst for change for pharma companies.
Source: Deloitte United StatesCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1PharmStars - 9 month(s) ago
PharmStars is the first and only pharma-focused accelerator for digital health startups, dedicated to driving digital health adoption to improve patient outcomes.
Source: www.pharmstars.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
Microbes have lost their monopoly as the sole source of new enzymes that can be easily programmed to make precise edits to the genome. Two independent teams, both led by scientists from the Massachusetts Institute of Technology, unveiled new gene editing tools on Wednesday based on proteins called
Source: Endpoints NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
RT @RobertFWright: Here's why a #biopharma exec founded a game-changing conference - The CNS Summit https://t.co/Ag6fdUBx5M https://t.co/67…